Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Eli-Lilly
Company Monitoring Page for Eli-Lilly
latest headlines for company on cafepharma
Eli Lilly, Incyte axe Olumiant in lupus amid eczema stalemate at FDA
Fierce Pharma
Fri, 01/28/22 - 11:47 am
Tags:
Eli Lilly
,
Incyte
,
olumiant
,
FDA
,
lupus
,
eczema
Eli Lilly plans €400m Irish plant that will create 800 jobs
Pharmaforum
Fri, 01/28/22 - 10:13 am
Tags:
Eli Lilly
,
Ireland
,
biologics
,
drug manufacturing
FDA bans use of Lilly, Regeneron COVID drugs due to Omicron
Pharmaforum
Tue, 01/25/22 - 10:44 am
Tags:
COVID-19
,
Eli Lilly
,
Regeneron
,
antibodies
,
Omicron COVID-19 variant
Trulicity Instagram post draws OPDP’s first untitled letter of 2022
RAPS.org
Mon, 01/24/22 - 11:37 pm
Tags:
Eli Lilly
,
Trulicity
,
OPDP
,
FDA
,
social media
Confidence is high for Eli Lilly CEO Ricks in showdown with Biogen's Aduhelm
Fierce Biotech
Fri, 01/21/22 - 11:13 am
Tags:
Eli Lilly
,
Biogen
,
Alzheimer's disease
,
Aduhelm
,
donanemab
,
clinical trials
,
David Ricks
Eli Lilly lines up metabolic pacts with Evotec, Abbisko as it awaits diabetes med nod from FDA
Fierce Biotech
Tue, 01/18/22 - 11:49 pm
Tags:
Eli Lilly
,
Evotec
,
Abbisko Therapeutics
,
diabetes
Two new drugs added to WHO list of COVID-19 therapies
Pharmaforum
Mon, 01/17/22 - 10:26 am
Tags:
WHO
,
COVID-19
,
Eli Lilly
,
olumiant
,
GSK
,
Vir Biotechnololgy
,
sotrovimab
Biotech investors pray for a takeover miracle
EP Vantage
Fri, 01/14/22 - 11:09 am
Tags:
M&A
,
biotech
,
Amylyx Pharmaceuticals
,
Arena Pharmaceuticals
,
AstraZeneca
,
Aurinia Pharmaceuticals
,
Biogen
,
Biohaven
,
Bristol Myers Squibb
,
Eli Lilly
,
GSK
,
Merck
,
Novartis
,
Novo Nordisk
,
Pfizer
,
Sanofi
7 drugs likely to hit $1B in annual revenue in the next 5 years
Beckers Hospital Review
Thu, 01/13/22 - 07:31 am
Tags:
FDA
,
adagrasib
,
donanemab
,
faricimab
,
lecanemab
,
tezepelumab
,
tirzepatide
,
vutrisiran
,
Eli Lilly
,
Mirati Therapeutics
,
Roche
,
Chugai
,
Eisai
,
Biogen
,
AstraZeneca
,
Amgen
,
Alnylam
JPM22, Day 3: In short order, Perrigo part of a new landscape; Legend, J&J prep for cilta-cel launch
Fierce Pharma
Wed, 01/12/22 - 11:22 pm
Tags:
JPMHC 2022
,
Bausch Health
,
Amgen
,
Eli Lilly
,
Perrigo
,
JNJ
,
Legend Biotech
JPM 2022: Eli Lilly CEO mulls using Novo's double-branding trick on tirzepatide—one obesity, one diabetes
Fierce Pharma
Wed, 01/12/22 - 11:10 am
Tags:
JPMHC 2022
,
Eli Lilly
,
Dave Ricks
,
tirzepatide
,
diabetes
,
obesity
Biopharma’s stock market winners of 2021 revealed
EP Vantage
Wed, 01/12/22 - 10:50 am
Tags:
biotech stocks
,
Eli Lilly
,
Pfizer
,
Abbott Labs
,
Moderna Therapeutics
,
Merck KGaA
,
Novo Nordisk
,
BioNTech
,
Biohaven
,
Prothena
,
Bicycle Therapeutics
,
Bellus Health
,
Evolus
Eli Lilly taps Entos' delivery tech in $50M-plus nucleic acid pact
Fierce Biotech
Thu, 01/6/22 - 11:22 am
Tags:
Eli Lilly
,
Entos Pharmaceuticals
,
proteolipid vehicles
,
drug delivery
2022 forecast: How marketers must learn from Biogen's marketing struggles with Aduhelm
Fierce Pharma
Mon, 12/27/21 - 11:10 am
Tags:
Biogen
,
Aduhelm
,
pharma marketing
,
Alzheimer's disease
,
Roche
,
Eli Lilly
Lilly's Phase 3 Study Of Lebrikizumab In Atopic Dermatitis Meets All Goals
NASDAQ
Tue, 12/21/21 - 10:30 am
Tags:
Eli Lilly
,
lebrikizumab
,
monoclonal antibodies
,
atopic dermatitis
,
clinical trials
Eli Lilly enters strike mode ahead of pivotal Alzheimer's, diabetes launches, CFO says
Fierce Pharma
Mon, 12/20/21 - 11:04 am
Tags:
Eli Lilly
,
Alzheimer's disease
,
diabetes
,
donanemab
,
tirzepatide
Eli Lilly joins Verge Genomics’ $98M round as AI-discovered ALS drug nears clinic
MedCity News
Fri, 12/17/21 - 10:48 am
Tags:
Verge Genomics
,
Eli Lilly
,
ALS
,
artificial intelligence
,
funding
Lilly ups revenue forecast amid windfall from COVID-19 drugs
BioPharma Dive
Wed, 12/15/21 - 11:46 pm
Tags:
Eli Lilly
,
COVID-19
US pauses distribution of GSK/Vir's Covid mAb not due to Omicron, but greater supply of Eli Lilly mAbs
Endpoints
Wed, 12/15/21 - 10:42 am
Tags:
GSK
,
Vir Biotechnology
,
Eli Lilly
,
monoclonal antibodies
,
COVID-19
Lilly and Foghorn Announce Strategic Collaboration for Novel Oncology Targets Using Foghorn's Proprietary Gene Traffic Control® Platform
PR Newswire
Mon, 12/13/21 - 10:51 am
Tags:
Eli Lilly
,
Foghorn Therapeutics
,
oncology
Pages
« first
‹ previous
…
26
27
28
29
30
31
32
33
34
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
a dog would most likely chase a: cat, rock, house
*
Fill in the blank.